Brent Hatzis-Schoch, See Remarks at Black Diamond Therapeutics, Inc. (BDTX), sold 6,763 shares at $30.76 ($209K) on 2020-09-14, disclosed to the SEC on 2020-09-16.
Open-market sale of $209k BDTX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.76 | 2,685 | $83K | 39.5% |
| 2 | $30.76 | 2,685 | $83K | 39.5% |
| 3 | $31.42 | 1,186 | $37K | 17.8% |
| 4 | $32.55 | 207 | $7K | 3.2% |
| Total | $30.93 avg | 6,763 | $209K | 100% |
| Filing → |
| BDTX | SELL | 2021-03-16 | $215K | — | Filing → |
| BDTX | SELL | 2021-02-12 | $214K | — | Filing → |
| BDTX | SELL | 2021-01-14 | $506K | — | Filing → |